These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 13230794)

  • 1. [Intravenous virus vaccine confers equal protection in experimental plague infection induced by three varieties of Pasteurella pestis].
    GIRARD G
    Bull Soc Pathol Exot Filiales; 1954; 47(4):475-8. PubMed ID: 13230794
    [No Abstract]   [Full Text] [Related]  

  • 2. STUDIES OF PASTEURELLA PESTIS. I. MODIFICATION OF INFECTION IN MICE BY PROTEINS OF PASTEURELLA PESTIS.
    EISLER DM; KUBIK GM; VONMETZ E
    J Immunol; 1963 Oct; 91():498-505. PubMed ID: 14082036
    [No Abstract]   [Full Text] [Related]  

  • 3. [Wild rodents infected with Pasteurella pestis in Argentina].
    DE LA BARRERA JM
    Bull World Health Organ; 1953; 9(5):701-5. PubMed ID: 13115988
    [No Abstract]   [Full Text] [Related]  

  • 4. An experimental study on cellular immunity in Pasteurella pestis infection.
    BHATNAGAR SS; SHRIVASTAVA DL
    J Hyg (Lond); 1946 May; 44():307-13. PubMed ID: 20983007
    [No Abstract]   [Full Text] [Related]  

  • 5. Concomitant administration of Yersinia pestis specific monoclonal antibodies with plague vaccine has a detrimental effect on vaccine mediated immunity.
    Eyles JE; Butcher WA; Titball RW; Hill J
    Vaccine; 2007 Oct; 25(42):7301-6. PubMed ID: 17869388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STUDIES OF PASTEURELLA PESTIS. II. CELLULAR AND SEROLOGIC CHANGES ASSOCIATED WITH IMMEDIATE PROTECTION INDUCED BY FRACTION IB.
    EISLER DM; VONMETZ E; HECKLY RJ
    J Immunol; 1963 Oct; 91():506-11. PubMed ID: 14082037
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of Pasteurella pestis on certain aspects of metabolism in animals susceptible to plague. I. Effect of enzymatic tricarboxylic cycle inhibitors on animals infected with Pasteurella pestis toxin].
    DZHAPARIDZE MN; KULIKOVA VL
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Sep; 29(9):122-7. PubMed ID: 13605112
    [No Abstract]   [Full Text] [Related]  

  • 8. INFECTION-PROMOTING ACTIVITY OF HIGH MOLECULAR WEIGHT MICROBIAL POLYSACCHARIDES ON MOUSE PERITONEAL INFECTIONS WITH PASTEURELLA PESTIS.
    FRIEDBERG D; SHILO M
    J Infect Dis; 1965 Jun; 115():263-70. PubMed ID: 14331709
    [No Abstract]   [Full Text] [Related]  

  • 9. Application of the antibody neutralization reaction in differential diagnosis of the etiologic agent of plague and the study of mutual relations between the amount of fraction I and virulence in strains of the plague microbe (Pasteurella pestis).
    Timofeeva LA; Aparin GP
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):420-5. PubMed ID: 5752128
    [No Abstract]   [Full Text] [Related]  

  • 10. The action of Pasteurella pestis bacteriophage on Pasteurella, Salmonella, and Shigella.
    LAZARUS AS; GUNNISON JB
    J Bacteriol; 1947 Jul; 54(1):70. PubMed ID: 20255166
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on respiratory infection. II. The influence of aerosol particle size on infection of the guinea-pig with Pasteurella pestis.
    DRUETT HA; ROBINSON JM; HENDERSON DW; PACKMAN L; PEACOCK S
    J Hyg (Lond); 1956 Mar; 54(1):37-48. PubMed ID: 13319689
    [No Abstract]   [Full Text] [Related]  

  • 12. [Two complex media for differentiation of three varieties of Pasteurella pestis and Pasteurelle pseudotuberculosis].
    DEVIGNAT R; BOIVIN A
    Bull Soc Pathol Exot Filiales; 1953; 46(5):627-31. PubMed ID: 13150068
    [No Abstract]   [Full Text] [Related]  

  • 13. An optimized vaccine vector based on recombinant vesicular stomatitis virus gives high-level, long-term protection against Yersinia pestis challenge.
    Palin A; Chattopadhyay A; Park S; Delmas G; Suresh R; Senina S; Perlin DS; Rose JK
    Vaccine; 2007 Jan; 25(4):741-50. PubMed ID: 16959385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual strain of Pasteurella pestis isolated from a fatal human case of plague.
    WINTER CC; CHERRY WB; MOODY MD
    Bull World Health Organ; 1960; 23(2-3):408-9. PubMed ID: 13845309
    [No Abstract]   [Full Text] [Related]  

  • 15. Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis).
    Rocke TE; Iams KP; Dawe S; Smith SR; Williamson JL; Heisey DM; Osorio JE
    Vaccine; 2009 Dec; 28(2):338-44. PubMed ID: 19879228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yersinia pestis infection in three dogs.
    Orloski KA; Eidson M
    J Am Vet Med Assoc; 1995 Aug; 207(3):316-8. PubMed ID: 7628931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency of killed plague vaccines prepared from avirulent Yersinia pestis.
    Williams JE; Altieri PL; Berman S; Lowenthal JP; Cavanaugh DC
    Bull World Health Organ; 1980; 58(5):753-6. PubMed ID: 6975184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ecological interactions among Yersinia in their common reservoir, the rodent].
    Alonso JM
    Bull Soc Pathol Exot; 1999 Dec; 92(5 Pt 2):414-7. PubMed ID: 11000952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on plague. I. Purification and properties of the toxin of Pasteurella pestis.
    AJL SJ; REEDAL JS; DURRUM EL; WARREN J
    J Bacteriol; 1955 Aug; 70(2):158-69. PubMed ID: 13251981
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic activity of chlortetracycline in experimental plague caused by streptomycin resistant and sensitive strains of Pasteurella pestis].
    MAKAROVSKAIA LN; TINKER IS; ALESHINA EN
    Antibiotiki; 1959; 4():81-4. PubMed ID: 14420134
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.